Aquarius Surgical Technologies Inc. · CSE:ASTI
Aquarius Surgical Technologies — Investor Presentation (March 2021)
7 slides from Aquarius Surgical Technologies's investor presentation, March 2021
Slide 1: Aquarius Surgical Technologies Inc.
AACN AA~N Aquarius Surgical TECHNOLOGIES INC.
Slide 2: Who Are We
Who Are We Aquarius Surgical Technologies’ primary focus is the development, sale, distribution, marketing, and exploitation of technologies for use in surgical environments. Aquarius Surgical Technologies offers strong market potential in today’s medical world where the technology vertical is predi
Slide 3: Our Mission / Our Strategic Priorities
Our Mission Leadership is the development and delivery of innovative, state of the art, high performance, minimally invasive and practical laser solutions comprising technology, support, consumables, and education. Our Strategic Priorities At Aquarius Surgical Technologies, we are committed to drivi
Slide 4: Strategic Priorities
Strategic Priorities Investing in Our Strategic Priorities to Enable Long-term Sustainable Profitable Growth At Aquarius Surgical Technologies, we are committed to driving long-term sustainable profitable growth to our shareholders. Drive brand awareness and growth through increased, focused organic
Slide 5: Subsidiaries
Subsidiaries Surgical Lasers Inc. We are an international distributor, service, support, and training organization providing integrated laser-based solutions across multiple medical disciplines. Surgical Lasers Inc. has been instrumental in introducing some of the first and now most successful medic
Slide 6: The Management Team
The Management Team David J. Henniger Dr. Robert W Francis N. Gary Van Nest Dr. Stan Swierzewski Chairman M.D.,C.M. Director, CEO, III MD Founder, Chairman, CEO of Vice Chairman Chief of Urology Franmed Health, ASTI Director ASTI Director 6
Slide 7: Contact Us
Contact Us 890 Scollard Street, Toronto, Ontario M5R 1G4 +1 (877) 740-ASTI (2784) aquariussurgical.com 7
Aquarius Surgical Technologies — Investor Presentation (March 2021) on 6ix